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Objective 20 
To estimate the incidence of congenital syphilis in the UK.  21 
Design 22 
Prospective study 23 
Setting and population 24 
United Kingdom 25 
Methods 26 
Children born between February 2010 and January 2015 with a suspected diagnosis of 27 
congenital syphilis were reported through an active surveillance system. 28 
Main outcome measures 29 
Number of congenital syphilis cases and incidence.  30 
Results 31 
For all years reported incidence was below the WHO threshold for elimination (<0.5/1000 32 
live births). 17 cases (male=12, female=5) were identified.  About 50% of infants (8/17) were 33 
born preterm (<37 weeks gestation): median birth weight 2000g (865g - 3170g). Clinical 34 
presentation varied from asymptomatic to acute disease, including severe anaemia, 35 
hepatosplenomegaly, rhinitis, thrombocytopaenia, skeletal damage, and neurosyphilis. One 36 
infant was deaf and blind. Median maternal age was 20 years (17 - 31) at delivery. Where 37 
maternal stage of infection was recorded, 6/10 had primary, 3/10 secondary and 1/10 early 38 
latent syphilis. Most mothers were white (13/16). Country of birth was recorded for 12 39 
mothers: UK (6), Eastern Europe (3), Middle East (1), and SE Asia (2). Social circumstances 40 
of mothers varied and included drug use and sex work. Some experienced difficulty 41 
accessing health care.  42 
Conclusions   43 
The incidence of congenital syphilis is controlled and monitored by healthcare services and 44 
related surveillance systems, and is now below the WHO elimination threshold. However, 45 
reducing the public health impact of this preventable disease in the UK is highly dependent 46 
on the successful implementation of WHO elimination standards across Europe. 47 
Key words Congenital syphilis, Epidemiology, Elimination, United Kingdom. 48 
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 49 
Tweetable abstract  50 
Congenital syphilis incidence in the UK is at a very low level and well below the WHO 51 
elimination threshold. 52 
Introduction    53 
Alongside the re-emergence of infectious syphilis in adults at the beginning of the 21st 54 
century, there has been an increase in the number of reports of congenitally acquired 55 
syphilis. Between 2001 and 2009 around nine diagnoses of congenital syphilis were 56 
reported annually by Genitourinary Medicine (GUM) services but information from outbreak 57 
investigations and case reports suggested that congenital syphilis was more widespread1-4. 58 
Diagnoses of infectious syphilis in reproductive age women fell from 268 in 2010 to 206 in 59 
2013 (Figure 1)5. The uptake of antenatal screening in England rose from 96.6% in 2010 to 60 
97.9% in 20136. Despite the high antenatal screening coverage concerns were raised about 61 
the effectiveness of case management and control strategies7. This study was instigated in 62 
2010 to estimate the incidence of congenital syphilis. The elimination of congenital syphilis 63 
from the UK was considered within the framework of the 2013 WHO guidelines for validating 64 
the elimination of mother to child transmission of syphilis8. 65 
 66 
Methods 67 
The methodology was based on that described by Hurtig et al. (1998) in the previous UK 68 
study of congenital syphilis undertaken between 1994 and 19979. Briefly, an initial dataset 69 
was created by combining returns made through the British Paediatric Surveillance Unit’s 70 
(BPSU) active surveillance system with laboratory reports (voluntary reporting), diagnoses 71 
reported through the GUM Clinic Activity Dataset (GUMCAD) (mandatory reporting), the 72 
national STI surveillance dataset, and ad hoc reports made by healthcare professionals10. 73 
The surveillance case definitions used during this initial data collection phase were as 74 
inclusive as possible. Paediatricians were asked to report ‘any child under the age of 24 75 
months with a confirmed or presumptive diagnosis of congenital syphilis or acquired syphilis’ 76 
born between February 2010 and January 2015 inclusive. This definition was also used for 77 
ad hoc reports. Interrogation of Public Health England (PHE) laboratory report data was 78 
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undertaken every three months to identify children under the age of 24 months who had 79 
evidence of exposure to Treponema pallidum. The GUMCAD dataset was searched for 80 
diagnoses of congenital syphilis annually10. All reports of suspected cases were followed up 81 
through letters, telephone calls and emails to paediatricians and microbiologists as the 82 
suspected cases were found. No limit was placed on length of time taken to capture the 83 
required information. The final surveillance dataset was created after harmonisation with 84 
data from the Surveillance of Antenatal Syphilis Screening (SASS) study which obtained 85 
data on all pregnant women testing positive for syphilis in 2010 and 2011 to evaluate the UK 86 
national antenatal syphilis screening programme11. 87 
 88 
Diagnoses of congenital syphilis were classified using the criteria given in the US Centers for 89 
Disease Control and Prevention Morbidity and Mortality Weekly Report (1997) (Table 1)12. 90 
These criteria are in line with the WHO definition of congenital syphilis in its guidelines for 91 
the elimination of mother-to-child transmission of syphilis8. Reports from the different 92 
surveillance sources were de-duplicated and the remaining followed-up using a 93 
questionnaire. Data were collected on infant and maternal demographic characteristics 94 
including ethnicity and country of birth, clinical presentation, health services attended, stage 95 
of infection (mother only), microbiological results, treatment and clinical management. 96 
Gestational age was calculated using the date of the last menstrual period. Follow-up was 97 
not attempted beyond that required to establish a positive or negative diagnosis of 98 
congenital syphilis in the infant. No estimate of fetal loss was made. For the purposes of this 99 
paper confirmed, presumptive and possible diagnoses (Table 1) were considered to be 100 
cases of congenital syphilis. Negative diagnoses were based on microbiological and clinical 101 
evidence. 102 
 103 
During this study, faulty batches of a syphilis laboratory test which carried an increased risk 104 
of false positive results were identified13. The IgM test results for the congenital syphilis 105 
cases identified when this batch was in use were verified by PHE Microbiology Services. 106 
 107 
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The numerator for the calculation of the annual incidence of congenital syphilis in the UK 108 
was the number of cases detected through the surveillance system described here; the 109 
denominator consisted of the number of estimated live births in the UK during the time 110 
period covered by this study (Official Statistics). Further information on the populations from 111 
which the cases were drawn was not collected and was not available from official 112 
demographic datasets. Findings from this and other published investigations were compared 113 
against the incidence and process targets given in the WHO framework for the elimination of 114 
mother-to-child transmission of syphilis to assess whether congenital syphilis incidence 115 
within the UK had reached elimination8. 116 
 117 
Results  118 
A total of 175 reports were received and investigated between February 2010 and January 119 
2015 inclusive, around 35 per annum. Information was derived from laboratory reports (113), 120 
BPSU returns (62), GUM clinics (0), the SASS Survey (3) and ad hoc reports (1) (four 121 
reports were derived from more than one information source). Seventeen reports were 122 
classified as cases (3 confirmed, 13 presumptive, one possible). The remaining 158 reports 123 
were subsequently classified as negative. Although a similar number of reports were 124 
identified and investigated in each of the five years, 10 of the 17 cases were born in 2010 125 
(Figure 2). About 50% of the cases (8/17) were born preterm at <37 weeks gestation, these 126 
infants having a median birth weight of 2000g (range: 865g to 3170g). No multiple births 127 
were reported. 128 
 129 
Clinical presentation of the 17 cases (12 male, 5 female) varied from asymptomatic (7/17) to 130 
acute, with symptoms including severe anaemia, hepatosplenomegaly, rhinitis, oedema, 131 
thrombocytopaenia, skeletal damage and neurosyphilis. One infant was deaf and blind. One 132 
case was an intrauterine death (second trimester). A stillbirth (34 weeks) was also 133 
investigated but although the mother had serological evidence of syphilis infection no 134 
evidence of congenital syphilis was seen in the infant. The cause of death was fetal 135 
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thrombotic vasculopathy. Four of the 16 surviving children were reported to have been taken 136 
into the care of social services. 137 
 138 
Two mothers were diagnosed between 20 and 30 weeks gestation and two just over a 139 
month before they gave birth. Three mothers were diagnosed in the last month of pregnancy 140 
(includes one concealed pregnancy), five at delivery and five after delivery. Median maternal 141 
age at delivery was 20 (range: 17 to 31). Of the 16 mothers for whom ethnicity was recorded 142 
13 were white. Country of birth was only available for 12/17 women: six were born in the UK, 143 
four of the 12 in Eastern Europe and the Middle East, and two in South East Asia.  144 
 145 
Although reports were received from all parts of the UK, cases were only seen in England. 146 
Individual cases were seen in all English regions. A geographic cluster consisting of a 147 
number of suspected reports of congenital syphilis, including one which was subsequently 148 
defined as a case, was identified in a group of Eastern European migrants. This highly 149 
unusual incident was managed by a local outbreak control team. 150 
 151 
Stage of infection was recorded for 10 mothers, six of whom presented with primary syphilis, 152 
three with secondary and one with early latent syphilis. All mothers diagnosed with syphilis 153 
were managed according to British Association of Sexual Health and HIV Guidelines and 154 
many were the subject of further investigations by local Health Protection Units14,15. The 155 
social circumstances of mothers varied and included injecting drug use, sex work and 156 
imprisonment, and some had experienced difficulty accessing healthcare due to cultural 157 
barriers.  158 
 159 
Comparability with WHO elimination guidelines 160 
For each year studied the incidence of congenital syphilis was well below the WHO 161 
threshold of <0.5/1000 live births (Table 2): 0.0149/1000 births (2010), 0.0025/1000 (2011), 162 
0.0025/1000 (2012), 0.0026/1000 (2013) and 0.0013/1000 (2014).  163 
Discussion  164 
Main findings 165 
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The WHO seeks to eliminate congenital syphilis using a three step strategy; universal 166 
access to antenatal care, including screening for syphilis, access to care in early pregnancy, 167 
and on-site testing and treatment supported by clearly structured healthcare pathways17. In 168 
the UK, this well established strategy is supported by open access, free and confidential 169 
GUM services, including partner notification, a combination of interventions that has kept 170 
incidence below the WHO elimination threshold. These interventions have been successful 171 
in achieving the WHO Europe targets for the elimination of congenital syphilis (Table 2). 172 
 173 
At the nadir of the syphilis epidemic in the mid-1990s Hurtig et al. identified nine presumptive 174 
and eight possible cases of congenital syphilis which represented an incidence of 175 
0.006/1000 live births, findings that were sufficient to ensure that antenatal screening was 176 
retained into the 21st century9,18. Although incidence was less than half that reported by 177 
Hurtig et al. from 2011 to 2014 our study indicated that congenital syphilis continues to 178 
present a complex clinical, social and public health problem in the UK. For example, several 179 
of the mothers had experienced difficulties accessing healthcare and consequently most 180 
children diagnosed with congenital syphilis were born to women who presented to antenatal 181 
services close to delivery. Another example of the difficult social circumstances of some of 182 
the families involved was that several children were taken into the care of social services. 183 
Although some congenital syphilis cases were asymptomatic, clinical presentation varied 184 
substantially and in some cases was life threatening. In contrast Hurtig et al. only reported 185 
clinical abnormalities in three of their 17 cases: two had signs on x ray, one osteochondritis 186 
of the skull, and the third had hepatosplenomegaly, rhinitis, odema and thrombocytopenia. 187 
 188 
Strengths and limitations 189 
The characteristics of surveillance systems vary in relation to their purpose. Here data were 190 
drawn from a number of systems. Whilst this was a strength of the investigation in that it 191 
allowed as many suspected cases as possible to be captured it also resulted in the collection 192 
of several overlapping datasets. For example, the laboratory data did not correspond exactly 193 
with the BPSU reports because the laboratory report system relies on voluntary reporting as 194 
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does the referral of samples for confirmatory testing. Suspected cases reported by more 195 
than one source were de-duplicated prior to analysis. 196 
 197 
The small number of detected cases presented a number of challenges: in particular 198 
providing a detailed insight into the epidemiology of this rare disease whilst preserving 199 
patient confidentiality. Consequently cross tabulations have not been shown and no 200 
information has been presented that could identify individuals. 201 
 202 
Interpretation 203 
The past decade has seen increased population movement across the European Union. In 204 
this study several of the mothers of children with congenital syphilis were born in Eastern 205 
Europe and the Middle East whereas none of the cases described by Hurtig et al. twenty 206 
years earlier were linked to these regions. Historically Eastern Europe has experienced a 207 
high rate of infectious syphilis diagnoses amongst women of reproductive age and this was 208 
reflected in the findings of this study including the outbreak control team investigation of the 209 
cluster. Social marginalisation of such migrants has also been suggested as a factor that has 210 
contributed to a resurgence of congenital syphilis in Italy19. Unfortunately it is difficult to 211 
compare trends in incidence and screening coverage between European countries because 212 
of variations in methodology20. Antenatal screening coverage is below the WHO target 213 
across Eastern Europe and, for some minority groups living in marginalised settlements, 214 
access to antenatal care and sexual health services is limited21. 215 
 216 
The WHO target seeks to support the elimination of mother-to-child transmission of syphilis 217 
worldwide. This encompasses a wide variety of healthcare systems that seek to control 218 
distinctly different epidemics. It is for individual countries to use the information from the 219 
impact and process indicators to refine local control strategies even if the target has been 220 
met. For example, the presence of diagnoses of congenital syphilis within the UK indicates 221 
gaps in coverage of the antenatal care delivery systems and syphilis intervention strategies 222 
aimed at adults. Identifying women at high risk of infection and encouraging them to attend 223 
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clinical services in early pregnancy is challenging. Local, proactive multi-agency 224 
interventions aimed at improving service access for women, their children and sexual 225 
partners in communities that have low rates of general practice registration and antenatal 226 
care attendance could play a vital role in increasing engagement with healthcare services. 227 
Clinicians also need to develop ways of identifying vulnerable women who may present late 228 
for antenatal care and who are at risk of missing out on appropriate interventions22.  229 
 230 
Conclusion 231 
Congenital syphilis in the UK continues to be contained by maintaining high quality 232 
healthcare services including antenatal screening, and related surveillance systems. A 233 
possible reduction in incidence since 2010 may suggest that vulnerable groups are engaging 234 
with health services. Achieving further reductions is highly dependent on the successful 235 
implementation and maintenance of WHO standards for the elimination of mother to child 236 
transmission of syphilis across Europe.  237 
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Table 1 Summary of congenital syphilis case definitions adapted from MMWR 1997 
and Hurtig et al. 19989,12 
 
Definition 
1 Confirmed* (definite†) 
Demonstration of Treponema pallidum by darkfield microscopy, fluorescent antibody, or other specific stains 
in specimens from lesions, placenta, umbilical cord, or autopsy material.  Also included specimens shown to 
be positive as a result of polymerase chain reaction (PCR) testing†† 
2 Presumptive (probable†)  
(i) A condition affecting an infant whose mother had untreated or inadequately treated syphilis at delivery, 
regardless of signs in the infant; or  
(ii) An infant or child who has a reactive treponemal test for syphilis; 
and any one of the following: 
o a reactive fluorescent treponemal antibody absorbed—19S-IgM antibody test or IgM enzyme-linked 
immunosorbent 
o any evidence of congenital syphilis on physical examination 
o any evidence of congenital syphilis on radiographs of long bones 
o a reactive cerebrospinal fluid (CSF) venereal disease research laboratory (VDRL) 
o an elevated CSF cell count or protein (without other cause) 
3 Possible**† 
Infants where congenital syphilis was indicated but for whom laboratory results were either not recorded or 
inconclusive. For example, where the result of the infant’s IgM test was positive but no corresponding 
information was recorded for the mother.
*  Direct detection of T. pallidum was performed on three reports: one infant was negative, the others positive. 
†  Terminology used by Hurtig et al.9 
** Not included in MMWR definition but used by Hurtig et al.9 
†† Criteria extended to include PCR diagnosis to reflect current diagnostic practice. 
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Table 2 WHO targets for validating the elimination of mother to child transmission of 
infectious syphilis8 
Targets Criteria met? 
Impact  
≤50 cases of congenital syphilis per 100 000 (0.5/1000) live births  Yes 
Process  
Antenatal care coverage (at least one visit) of ≥95% Yes16 
Coverage of syphilis testing of pregnant women of ≥95% Yes6 
Treatment of syphilis seropositive pregnant women of ≥95% Yes11* 
*96.1% (516/537) of seropositive women requiring treatment in pregnancy (i.e. with active newly diagnosed infection 
or uncertainty about previous treatment) treated effectively (SASS study data)11 
